Synthesis of α-gal epitopes on influenza virus vaccines, by recombinant α1,3galactosyltransferase, enables the formation of immune complexes with the natural anti-Gal antibody

Vaccine

Volumn 15, Issue 11, 1997, Pages 1174-1182

  Henion, Timothy R ^a   Gerhard, Walter ^b   Anaraki, Farvardin ^a   Galili, Uri ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b WISTAR INSTITUTE   (United States)

Author keywords

1,3galactosyltransferase; gal epitope; Anti Gal; Influenza virus

Indexed keywords

ANTIBODY; EPITOPE; GALACTOSE; GALACTOSYLTRANSFERASE; INFLUENZA VACCINE; RECOMBINANT GALACTOSYLTRANSFERASE; UNCLASSIFIED DRUG; VIRUS HEMAGGLUTININ;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; IMMUNOGENICITY; INSECT; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; VACCINE PRODUCTION; VIRION;

ANIMALS; ANTIBODY SPECIFICITY; ANTIGEN-ANTIBODY REACTIONS; BACULOVIRIDAE; BIOMEDICAL ENGINEERING; CELL LINE; CLONING, MOLECULAR; CULICIDAE; EPITOPES; GALACTOSE; GALACTOSYLTRANSFERASES; INFLUENZA VACCINES; MEMBRANE GLYCOPROTEINS; RECOMBINANT PROTEINS; VIRAL PROTEINS;

EID: 0030829012     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(96)00300-3     Document Type: Article

References (44)

1. Celis, E., Abraham, K.G. and Miller, R.W. Modulation of the immunological response to hepatitis B virus by antibodies. Hepatology 1987, 7, 563-568.
2. Houston, W.E., Kremer, R.J., Crabbs, C.L. and Spertzel, R.O. Inactivated Venezuelan equine encephalomyelitis virus vaccine complexed with specific antibody: enhanced primary immune response and altered pattern of antibody class elicited. J. Infect. Dis. 1977, 7, 600-610.
3. Celis, E. and Chang, T.W. Antibodies to hepatitis B surface antigen potentiate the response of human T lymphocyte clones to the same antigen. Science 1984, 224, 297-299.
4. Manca, F., Fenoglio, D., LiPira, G., Kunkl, A. and Celada, F. Effect of antigen/antibody ratio on macrophage uptake, processing and presentation to T cells of antigen complexed with polyclonal antibodies. J. Exp. Med. 1991, 173, 37-48.
5. Gosselin, E.J., Wardwell, K., Gosselin, D.R., Alter, N., Fisher, J.L. and Guyre, P. Enhanced antigen presentation using human Fcγ receptor (monocyte/macrophage)-specific immunogens. J. Immunol. 1992, 149, 3477-3481.
6. Liu, C., Gosselin, E. and Guyre, P. FcγRII on human B cells can mediate enhanced antigen presentation. Cell. Immunol. 1996, 167, 188-194.
7. Sallusto, F. and Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus Interleukin 4 and down regulated by tumor necrosis factor α. J. Exp. Med. 1994, 179, 1109-1112.
8. Fanger, N.A., Wardwell, K., Shen, L., Tedder, T.F. and Guyre, P.M. Type I (CD64) and Type II (CD32) Fc receptor-mediated phagocytosis by human blood dendritic cells. J. Immunol. 1996, 157, 541-548.
9. Galili, U., Rachmilewitz, E.A., Peleg, A. and Flechner, I. A unique natural human IgG antibody with anti-α-Galactosyl specificity. J. Exp. Med. 1984, 160, 1519-1531.
10. Galili, U. Evolution and pathophysiology of the human natural anti-Gal antibody. Springer Semin. Immunopathol. 1993, 15, 155-171.
11. Galili, U., Macher, B.A., Buehler, J. and Shohet, S.B. Human natural anti-α-Galactosyl IgG. II. The specific recognition of α(1→3)-linked galactose residues. J. Exp. Med. 1985, 162, 573-582.
12. Galili, U., Buehler, J., Shohet, S.B. and Macher, B.A. The human natural anti-Gal IgG. III. The subtlety of immune tolerance in man as demonstrated by crossreactivity between natural anti-Gal and anti-B antibodies. J. Exp. Med. 1987, 165, 693-704.
13. Galili, U., Clark, M.R., Shohet, S.B., Buehler, J. and Macher, B.A. Evolutionary relationship between the anti-Gal antibody and the Galα1→3Gal epitope in primates. Proc. Natl Acad. Sci. USA 1987, 84, 1369-1373.
14. Galili, U., Shohet, S.B., Kobrin, E., Stults, C.L.M. and Macher, B.A. Man, apes, and Old World monkeys differ from other mammals in the expression of α-Galactosyl epitopes on nucleated cells. J. Biol. Chem. 1988, 263, 17755-17762.
15. Thall, A., Etienne-Decerf, J., Winand, R. and Galili, U. The α-Galactosyl epitope on mammalian thyroid cells. Acta. Endocrinol. 1991, 124, 692-699.
16. Repik, P.M., Strizki, J.M. and Galili, U. Differential host dependent expression of α-Galactosyl epitopes on viral glycoproteins: a study on eastern equine encephalitis virs as a model. J. Gen. Virol. 1994, 75, 1177-1181.
17. Rother, R.P., Fodor, W.L. and Springhorn, J.P. et al. A novel mechanism of retrovirus inactivation in human serum mediated by α-Galactosyl natural antibody. J. Exp. Med. 1995, 18, 1345-1355.
18. Takeuchi, Y., Porter, C.D. and Strahan, K.M. et al. Sensitization of cells and retroviruses to human serum b α1 ,3galactosyltransferase. Nature 1996, 379, 85-88.
19. Rother, R.P. and Squinto, S.P. The α-Galactosyl epitope: a sugar coating that makes viruses and cells unpalatable. Cell 1996, 86, 185-188.
20. Galili, U., Repik, P.K., Anaraki, F., Mozdzanowska, K., Washko, G. and Gerhard, W. Enhancement of antigen presentation of influenza virus hemagglutinin by the natural anti-Gal antibody. Vaccine 1996, 14, 321-328.
21. D'Alessio, D.J., Cox, P.M. and Dick, E.C. Failure of inactivated influenza vaccine to protect an aged population. J. Am. Med. Assoc. 1969, 210, 485-489.
22. Howells, C.H.L., Vesselenova-Jenkins, C.K., Evans, A.D. and James, J. Influenza vaccination and mortalility from broncho pneumonia in the elderly. Lancet 1975, 1, 381-383.
23. Gross, P.A., Hermogenes, A.W., Sacks, H.S., Lau, J. and Levandowski, R.A. The efficacy of influenza vaccine in elderly persons. Ann. Intern. Med. 1995, 123, 518-525.
24. Nichol, K.L., Margolis, K.L., Wuorema, J. and Von Sternberg, T. The efficacy and cost effectiveness of vaccinating against influenza among elderly persons living in the community. N. Engl. J. Med. 1994, 331, 778-784.
25. Gravenstein, S., Drinka, P.J. and Duthie, E.H. et al. Risks for influenza and repiratory illness in vaccinated elderly. Aging: Immunol. Infect. Dis. 1990, 2, 185-193.
26. Klinman, N. and Liu, M.A. Age-related immune disfuction and response to vaccination. Report of the Task Force on Immunology and Aging. National Institute on Aging and National Institute of Allergy and Infectious Diseases NIH Publication No. 96-4018, March 1996, NIH, pp. 73-77.
27. Henion, T.R., Macher, B.A., Anaraki, F. and Galili, U. Defining the minimal size of catalytically active primate α1,3galactosyltransferase: structure function studies on the recombinant truncated enzyme. Glycobiology 1994, 4, 193-201.
28. Skehel, J.J. and Waterfield, M.D. Studies on primary structure of influenza virus hemagglutinin. Proc. Natl Acad. Sci. USA 1975, 72, 93-97.
29. Wood, C., Kabat, E.A., Murphy, L.A. and Goldstein, I.J. Immunochemical studies of the combining sites of two isolectins A4 and B4 isolated from Bandeiraea simplicifolia. Arch. Biochem. Biophys. 1979, 198, 1-9.
30. Green, E.D., Adelt, G., Baenzinger, J.U., Wilson, S. and Van-Halbeck, H. The asparagine-linked oligosaccharides on bovine fetuin: Structural analysis of N-glycanase related oligosaccharides by 500-megahertz NMR spectoscopy. J. Biol. Chem. 1988, 263, 18253-18268.
31. Kornfeld, R. and Kornfeld, S. Assembly of asparagine-linked carbohydrate chains. Ann. Rev. Biochem. 1985, 54, 631-664.
32. Kiel, W., Geyer, R. and Dabrowski, J. et al. Carbohydrates of influenza virus. Structure elucidation of the individual glycans of the FPV hemagglutinin by two-dimensional H NMR and methylation analysis. EMBO JI. 1985, 4, 2711-2720.
33. Matsumoto, A., Yoshima, H. and Kobata, A. Carbohydrates of influenza virus hemagglutinin: structure of the whole neutral sugar chain. Biochemistry 1983, 22, 188-196.
34. Air, G.M., and Laver, W.G. Influenza viruses. In Immunochemistry of Viruses. II. The Basis for Serodiagnosis and Vaccines (Eds Van Regemorted, M.H.V., and Neurath, A.R.), Elsevier Science, Amsterdam, 1990, pp. 171-216.
35. Unkeless, J.C. Functional heterogeneity of human Fc receptors for immunoglobulin G. J. Clin. Invest. 1989, 83, 355-361.
36. Schmitt, D.A., Hanan, D. and Bieber, T. et al. Human epidermal Langerhans cells express only trhe 40-kilodalton Fcγ receptor (FcRII). J. Immunol. 1990, 144, 4284-4290.
37. Metlay, J.P., Pure, H. and Steinman, R.M. Distinct features of dendritic cells and anti-immunoglobulin activated B cells as stimulators of the primary mixed lymphocyte reaction. J. Exp. Med. 1989, 169, 239-254.
38. Scherle, P.A. and Gerhard, W. Differential ability of B cell specific for external vs. internal influenza virus proteins to respond to help from influenza-specific T-cell clones in vivo. Proc. Natl Acad. Sci. USA 1988, 85, 4446-4450.
39. Palladino, G., Scherle, P.A. and Gerhard, W. Activity of CD4+ T-cell clones of type 1 and type 2 in generation of influenza specific cytotoxic responses in vitro. J. Virol. 1991, 65, 6071-6076.
40. Bender, A., Bui, L.K., Feldman, M.A.V., Larsoon, M. and Bhardwaj, N. Inactivated influenza virus, when presented on dendritic cells, elicits human CD8+ cytolytic T cell responses. J. Exp. Med. 1995, 182, 1663-1671.
41. Joziasse, O.H., Shaper, N.L., Slayer, L.S., van den Eijnden, D.H., van der Spoel, A.C. and Shaper, J.H. α1,3Galactosyltransferase: the use of recombinant enzyme for the synthesis of α-Galactosylated glycoconjugates. Eur. J. Biochem. 1990, 191, 75-83.
42. Rademacher, T.W., Parekh, R.B. and Dwek, R.A. Glycobiology. Ann. Rev. Biochem. 1988, 57, 785-838.
43. Leonard, C.K., Spellman, M.W., Riddle, L., Harris, R.J., Thomas, J.N. and Gregory, T.J. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type I recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese Hamster Ovary cells. J. Biol. Chem. 1990, 265, 10373-10382.
44. Thall, A.D., Maly, P. and Lowe, J.B. Oocyte Galα1-3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J. Biol. Chem. 1995, 270, 21437-21442